According to filings with the U.S. Securities and Exchange Commission, Rakuten Medical is raising $123,689,146.00 in new funding. Sources indicate that as part of senior management President, Takashi Toraishi played a key role in securing…
According to filings with the U.S. Securities and Exchange Commission, Ospitek is raising $8,921,294.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Slim Souissi played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Inhibrx is raising $200,000,633.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Mark Lappe played a key role in…
According to filings with the U.S. Securities and Exchange Commission, Burl Concepts is raising $2,499,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Thilo Hoelscher played a key role…
According to filings with the U.S. Securities and Exchange Commission, Blast Motion is raising $60,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Michael Fitzpatrick played a key role…
According to filings with the U.S. Securities and Exchange Commission, AscentX Medical is raising $2,999,931.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Larry Braga played a…
According to filings with the U.S. Securities and Exchange Commission, Legion Works, Inc. is raising $25,640,000.00 in new funding. About Legion Works, Inc.: Legion is a group of experienced and successful entrepreneurs that acquire, build…
According to filings with the U.S. Securities and Exchange Commission, Turnstone Biologics is raising $80,000,000.00 in new funding. About Turnstone Biologics: Turnstone Biologics is a clinical-stage biotechnology company developing new medicines to treat and cure…
According to filings with the U.S. Securities and Exchange Commission, Spinogenix is raising $5,199,985.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, Stella Sarraf played a key…
According to filings with the U.S. Securities and Exchange Commission, Poseida Therapeutics is raising $24,999,999.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Eric Ostertag played a key role…